MENU
ZTS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
ZOETIS (ZTS) Ownership - Who owns ZOETIS?
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals... Show more
Industry: #Pharmaceuticals Generic
Profile
Industry
Pharmaceuticals Generic
Address
10 Sylvan Way
Phone
+1 973 822-7000
Employees
14100
Web
https://www.zoetis.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
67.83B
P/E Ratio
26.34
Total Cash
N/A
Projected Growth
2.48
Total Debt
6.75B
Revenue
N/A
Risk (Beta)
0.98
Dividend Yield
0.01
Total Cash/Share
N/A
Total Debt/Equity
332.85
Revenue/Share
20.88 USD as % of share price
Fundamentals
ZTS
Capitalization
67.8B
P/E Ratio
26.34
Risk (Beta)
0.98
Dividend Yield
0.01
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
6.75B
Total Debt/Equity
332.85
Projected Growth (PEG Ratio)
2.48
Revenue/Share (as % of the share price)
20.88%
Revenue
N/A
ROE
N/A
Book Value
4.66B
P/B Ratio
13.62
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5M
Current Ratio
1.74
Current Revenue Per Employee
160869.56
Dividends Per Share - Security
0.50
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
71.98
Revenue To Assets
N/A
Shares Held By Institutions
145B
Shares Outstanding - Current
443M
Total Liabilities
9.44B
Total Volume MTD
N/A
Value
N/A
Gain YTD
-5.140
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ZTS showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a pet medication company
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
10 Sylvan Way
Phone
+1 973 822-7000
Employees
14100
Web
https://www.zoetis.com